Oncothyreon Inc Message Board
-
downgrade just out on ONTY
Here it is:
"we decided to downgrade ONTY stock from strong short sell recommendation to single best short idea for the next 2 years. As expected, stimuvax showed huge side effects and the trial is now halted. We believe PX-866 is the next trial to be halted for lack of effectiveness. We also belive more stock dilution is coming for ONTY. ONTY is clearly the worst biotech stock we cover."
This is just out from our research department. So you see, I just provide high quality, unbiased information.
Thank you-
Hi Gaby...your avitar is winking at me!
- 1 Reply to strudellstemcell
-
Most "analysts" dont use hate words like Dumbass. ;-)
-
who is "we" ?? do you have a web site with recommendations?
-
Hey Gab,
What about a little lawsuit to force you to stick to the truth ?
Are you up for it ?- 1 Reply to balzqc
-
Hi ! What lawsuit ? I always tell the truth. Most people on this board appreciate the high quality research I provide. That's why many of my posts are rates 5 stars.
Thank you
-
Gaby, Nice headline to grab real investors attention. Now I see why some put you on "ignore".
IF it is unbiased, you certainly can mention the name of YOUR research department.
-